Technical Analysis for ORIC - Oric Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Boomer Buy Setup | Bullish Swing Setup | -2.78% | |
Pocket Pivot | Bullish Swing Setup | -2.78% | |
Volume Surge | Other | -2.78% | |
NR7 | Range Contraction | -2.78% | |
Earnings Movers | Other | -2.78% | |
Inside Day | Range Contraction | -2.78% | |
Wide Bands | Range Expansion | -2.78% | |
Earnings Movers | Other | -2.26% |
Alert | Time |
---|---|
Down 5% | about 17 hours ago |
10 DMA Resistance | about 17 hours ago |
Down 3% | about 17 hours ago |
Fell Below Previous Day's Low | about 17 hours ago |
Down 2 % | about 17 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/14/2024
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. Its lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. The company's second product candidate is ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. It is also developing multiple precision medicines targeting other cancer resistance mechanisms. The company was founded in 2014 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Immunotherapy Treatment Of Cancer Cancer Treatment Oncology Chemotherapy Antineoplastic Drugs Occupational Safety And Health Precision Medicine Specialty Drugs Cancer Therapeutics Cd73
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Immunotherapy Treatment Of Cancer Cancer Treatment Oncology Chemotherapy Antineoplastic Drugs Occupational Safety And Health Precision Medicine Specialty Drugs Cancer Therapeutics Cd73
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 16.63 |
52 Week Low | 4.6 |
Average Volume | 587,660 |
200-Day Moving Average | 8.60 |
50-Day Moving Average | 11.72 |
20-Day Moving Average | 13.59 |
10-Day Moving Average | 15.18 |
Average True Range | 0.99 |
RSI (14) | 59.84 |
ADX | 34.07 |
+DI | 28.00 |
-DI | 19.02 |
Chandelier Exit (Long, 3 ATRs) | 13.66 |
Chandelier Exit (Short, 3 ATRs) | 12.93 |
Upper Bollinger Bands | 17.56 |
Lower Bollinger Band | 9.61 |
Percent B (%b) | 0.64 |
BandWidth | 58.52 |
MACD Line | 1.04 |
MACD Signal Line | 1.07 |
MACD Histogram | -0.0311 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 16.18 | ||||
Resistance 3 (R3) | 16.19 | 15.69 | 15.93 | ||
Resistance 2 (R2) | 15.69 | 15.31 | 15.69 | 15.85 | |
Resistance 1 (R1) | 15.19 | 15.08 | 14.94 | 15.18 | 15.76 |
Pivot Point | 14.69 | 14.69 | 14.57 | 14.69 | 14.69 |
Support 1 (S1) | 14.19 | 14.31 | 13.94 | 14.18 | 13.60 |
Support 2 (S2) | 13.69 | 14.08 | 13.69 | 13.51 | |
Support 3 (S3) | 13.19 | 13.69 | 13.43 | ||
Support 4 (S4) | 13.18 |